Adaptive Designs in Clinical Trials
Author Information
Author(s): Bowalekar Suresh
Primary Institution: PharmaNet Clinical Services Pvt. Ltd.
Hypothesis
Can adaptive designs improve the efficiency and effectiveness of clinical trials?
Conclusion
Adaptive designs have the potential to reduce patient numbers and trial duration while maintaining scientific integrity.
Supporting Evidence
- Adaptive designs can lead to fewer patients being needed in trials.
- These designs allow for mid-course adjustments based on data collected during the trial.
- Regulatory bodies are increasingly supportive of adaptive trial designs.
Takeaway
Adaptive designs in clinical trials allow researchers to change the study as it goes along based on what they learn, which can save time and resources.
Methodology
The paper describes various adaptive designs and their feasibility based on stakeholder views.
Potential Biases
Risks include conducting unplanned interim analyses and adjusting final p-values without proper justification.
Limitations
The complexity of Bayesian approaches and potential for bias in unplanned interim analyses.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website